Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 11 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 546 (85%) | |
Discontinuation Reports |
234 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 234 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
81 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-BECLO AQ | 50MCG | SUSPENSION METERED-DOSE AEROSOL | Resolved | 2023-08-29 | 2024-02-29 | 203100 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-08-29 | 2023-10-03 | 203214 |
| MYLAN-CLOBETASOL CREAM | 0.05% | CREAM | Resolved | 2023-09-06 | 2023-12-19 | 203693 |
| MYLAN-CLOBETASOL SCALP APPLICATION | 0.05% | LOTION | Resolved | 2023-09-06 | 2023-11-06 | 203708 |
| MYLAN-SUMATRIPTAN | 25MG | TABLET | Resolved | 2023-09-11 | 2023-10-11 | 204095 |
| MYLAN-FLUCONAZOLE | 100MG | TABLET | Resolved | 2023-09-11 | 2023-09-26 | 204098 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-10-03 | 2024-01-10 | 205932 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-10-11 | 2023-11-28 | 206781 |
| MYLAN-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-10-17 | 2024-05-15 | 207184 |
| MYLAN-TADALAFIL | 20MG | TABLET | Resolved | 2023-10-17 | 2023-12-19 | 207187 |
| MYLAN-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2023-10-30 | 2024-03-25 | 208613 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2023-11-14 | 209413 |
| MYLAN-GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-11-06 | 2024-03-25 | 209416 |
| MYLAN-ALMOTRIPTAN | 6.25MG | TABLET | Resolved | 2023-12-13 | 2024-03-25 | 213129 |
| MYLAN-LAMOTRIGINE | 150MG | TABLET | Resolved | 2023-12-19 | 2024-01-19 | 213761 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 375MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2023-12-19 | 2024-01-16 | 213764 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-12-21 | 2024-01-10 | 213971 |
| MYLAN-MIRTAZAPINE | 30MG | TABLET | Resolved | 2024-01-22 | 2024-05-09 | 216953 |
| MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20MG 500MG | TABLET (IMMEDIATE AND DELAYED-RELEASE) | Resolved | 2024-01-30 | 2024-02-29 | 217867 |
| MYLAN-CILAZAPRIL | 5.0MG | TABLET | Resolved | 2024-03-06 | 2024-03-25 | 221438 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-NITRO SUBLINGUAL SPRAY | 0.4MG | METERED-DOSE AEROSOL | Discontinued | 2024-05-08 | 2024-05-08 | 227338 |